References
- The Sixth Report of the Joint National Committee on Prevention. Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–46
- Menard J., Chatellier G. Limiting factors in the control of BP: why is there a gap between theory and practice?. J Human Hypertens 1995; 9: S19–23
- Vander Stichele R. Measurement of patient compliance and the interpretation of randomized clinical trials. Eur J Clin Pharmacol 1991; 41: 27–35
- Rudd P. Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J 1995; 130: 572–9
- Degoulet P., Menard J., Vu H. A., Golmard J. L., Devries C., Chatellier G., Plouin PF. Factors predictive of attendance at clinic and blood pressure control in hypertensive patients. Br Med J 1983; 287: 88–93
- Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 1981; 2: 539–43
- Hershey J. C., Morton B. G., Davis J. B., Reichgott MJ. Patient compliance with antihypertensive medication. Am J Public Health 1980; 70: 1081–9
- Sackett D. L., Haynes R. B., Gibson E. S., Hackett B. C., Taylor D. W., Roberts R. S., Johnson AL. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet 1975; 1: 1205–7
- Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150: 1377–8
- McCombs J. S., Nichol M. B., Newman C. M., Sclar DA. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Medical Care 1994; 32: 214–26
- Monane M., Bohn R. L., Gurwitz J. H., Glynn R. J., Levin R., Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997; 10: 697–704
- Caro JJ. Stepped care for hypertension: are the assumptions valid?. J Hypertens 1997; 15(suppl 7)35–9
- Urquhart J. The electronic medication event monitor. Lessons for pharmacotherapy. Clin Pharmacokinet 1997; 32: 345–56
- Maronde R. F., Chan L. S., Larsen F. J., Strandberg L. R., Laventurier M. F., Sullivan SR. Underutilization of antihypertensive drugs and associated hospitalization. Medical Care 1989; 27: 1159–66
- Waeber B., Brunner H. R., Metry JM. Compliance with antihypertensive treatment: implications for practice. Blood Pressure 1997; 6: 326–31
- Miller N. H., Hill M., Kottke T., Ockene IS. The multilevel compliance challenge: recommendations for a call to action.A statement for healthcare professionals. Circulation 1997; 95: 1085–90
- McKenney J. M., Munroe W. P., Wright J. T., Jr. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol 1992; 32: 277–83
- Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 1995; 49: 321–27
- Friedman R. H., Kazis L. E., Jette A., Smith M. B., Stollerman J., Torgerson J., Carey K. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996; 9: 285–92
- Wallenius S. H., Vainio K. K., Korhonen M. J., Hartzema A. G., Enlund HK. Self-initiated modification of hypertension treatment in response to perceived problems. Ann Pharmacother 1995; 29: 1213–17
- Lip G. Y., Beevers DG. Doctors, nurses, pharmacists and patients—the Rational Evaluation and Choice in Hypertension (REACH) Survey of Hypertension Care Delivery. Blood Pressure 1997; 6(suppl 1)6–10
- Bailey J. E., Lee M. D., Somes G. W., Graham RL. Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care. Clin Ther 1996; 18: 1252–62
- Lee J. Y., Kusek J. W., Greene P. G., Bernhard S., Norris K., Smith D., Wilkening B., Wright J. T., Jr. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Am J Hypertens 1996; 9: 719–25